nodes	percent_of_prediction	percent_of_DWPC	metapath
Betaxolol—CYP2D6—Parkinson's disease	0.892	1	CbGaD
Betaxolol—Alprenolol—HTR1A—Parkinson's disease	0.00129	0.127	CrCbGaD
Betaxolol—Pindolol—HTR1A—Parkinson's disease	0.00111	0.109	CrCbGaD
Betaxolol—Bisoprolol—CYP2D6—Parkinson's disease	0.000902	0.0885	CrCbGaD
Betaxolol—Acebutolol—CYP2D6—Parkinson's disease	0.000854	0.0838	CrCbGaD
Betaxolol—Oxprenolol—CYP2D6—Parkinson's disease	0.000848	0.0832	CrCbGaD
Betaxolol—Alprenolol—CYP2D6—Parkinson's disease	0.000775	0.0761	CrCbGaD
Betaxolol—Metoprolol—CYP2D6—Parkinson's disease	0.000721	0.0708	CrCbGaD
Betaxolol—Pindolol—CYP2D6—Parkinson's disease	0.000667	0.0655	CrCbGaD
Betaxolol—Atenolol—ABCB1—Parkinson's disease	0.000661	0.0649	CrCbGaD
Betaxolol—Acebutolol—ABCB1—Parkinson's disease	0.00061	0.0599	CrCbGaD
Betaxolol—Propranolol—HTR1A—Parkinson's disease	0.000607	0.0595	CrCbGaD
Betaxolol—Metoprolol—ABCB1—Parkinson's disease	0.000515	0.0505	CrCbGaD
Betaxolol—Propranolol—CYP2D6—Parkinson's disease	0.000364	0.0357	CrCbGaD
Betaxolol—Propranolol—ABCB1—Parkinson's disease	0.00026	0.0255	CrCbGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000202	0.00206	CbGpPWpGaD
Betaxolol—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000198	0.00202	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000198	0.00201	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000191	0.00195	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000189	0.00193	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—MAOB—Parkinson's disease	0.000188	0.00192	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000187	0.0019	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000185	0.00189	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000183	0.00186	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000183	0.00186	CbGpPWpGaD
Betaxolol—CYP1A2—Phase II conjugation—COMT—Parkinson's disease	0.000181	0.00184	CbGpPWpGaD
Betaxolol—CYP1A2—Phase II conjugation—GSTP1—Parkinson's disease	0.00018	0.00184	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000179	0.00182	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000179	0.00182	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—GRK5—Parkinson's disease	0.000174	0.00178	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—GRK5—Parkinson's disease	0.00017	0.00174	CbGpPWpGaD
Betaxolol—CYP1A2—Phase II conjugation—GSTM1—Parkinson's disease	0.000165	0.00169	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—HTR1A—Parkinson's disease	0.000164	0.00168	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—TAC1—Parkinson's disease	0.000162	0.00165	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—HTR1A—Parkinson's disease	0.000161	0.00164	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—DRD1—Parkinson's disease	0.000159	0.00162	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—TAC1—Parkinson's disease	0.000158	0.00161	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—GRK5—Parkinson's disease	0.000158	0.00161	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—GRM4—Parkinson's disease	0.000156	0.00159	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—DRD1—Parkinson's disease	0.000155	0.00158	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—GRK5—Parkinson's disease	0.000155	0.00158	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—DRD3—Parkinson's disease	0.000154	0.00157	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—GRM4—Parkinson's disease	0.000153	0.00156	CbGpPWpGaD
Betaxolol—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000151	0.00154	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—DRD3—Parkinson's disease	0.00015	0.00153	CbGpPWpGaD
Betaxolol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000149	0.00152	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—VPS35—Parkinson's disease	0.000149	0.00152	CbGpPWpGaD
Betaxolol—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000149	0.00152	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PENK—Parkinson's disease	0.000148	0.00151	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000146	0.00149	CbGpPWpGaD
Betaxolol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000146	0.00149	CbGpPWpGaD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Parkinson's disease	0.000146	0.00149	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—VPS35—Parkinson's disease	0.000146	0.00148	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PENK—Parkinson's disease	0.000145	0.00148	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000143	0.00146	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—GRM4—Parkinson's disease	0.000142	0.00145	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—CYP2D6—Parkinson's disease	0.00014	0.00142	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—DRD2—Parkinson's disease	0.000139	0.00142	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—HTR7—Parkinson's disease	0.000139	0.00142	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—GRM4—Parkinson's disease	0.000139	0.00141	CbGpPWpGaD
Betaxolol—CYP1A2—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000138	0.0014	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—HTR7—Parkinson's disease	0.000136	0.00139	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—DRD2—Parkinson's disease	0.000136	0.00139	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000135	0.00138	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PENK—Parkinson's disease	0.000134	0.00137	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—PDYN—Parkinson's disease	0.000132	0.00135	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PENK—Parkinson's disease	0.000132	0.00134	CbGpPWpGaD
Betaxolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000128	0.0013	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—CYP2E1—Parkinson's disease	0.000128	0.0013	CbGpPWpGaD
Betaxolol—CYP1A2—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000126	0.00128	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000126	0.00128	CbGpPWpGaD
Betaxolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000125	0.00128	CbGpPWpGaD
Betaxolol—CYP2D6—Biological oxidations—COMT—Parkinson's disease	0.000125	0.00127	CbGpPWpGaD
Betaxolol—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	0.000124	0.00127	CbGpPWpGaD
Betaxolol—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	0.000124	0.00127	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GPR37—Parkinson's disease	0.000123	0.00126	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—DGKQ—Parkinson's disease	0.000123	0.00126	CbGpPWpGaD
Betaxolol—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	0.000123	0.00126	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—GRM5—Parkinson's disease	0.000123	0.00126	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—PDYN—Parkinson's disease	0.000123	0.00125	CbGpPWpGaD
Betaxolol—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000123	0.00125	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—DGKQ—Parkinson's disease	0.000121	0.00123	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GPR37—Parkinson's disease	0.000121	0.00123	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—PDYN—Parkinson's disease	0.00012	0.00123	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000117	0.00119	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—GRM5—Parkinson's disease	0.000114	0.00117	CbGpPWpGaD
Betaxolol—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	0.000114	0.00117	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PPP1R1B—Parkinson's disease	0.000113	0.00115	CbGpPWpGaD
Betaxolol—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000113	0.00115	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—GRM5—Parkinson's disease	0.000112	0.00114	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—EDN1—Parkinson's disease	0.000111	0.00114	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00011	0.00112	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—EDN1—Parkinson's disease	0.000109	0.00111	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000107	0.00109	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—COMT—Parkinson's disease	0.000106	0.00108	CbGpPWpGaD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Parkinson's disease	0.000106	0.00108	CbGpPWpGaD
Betaxolol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Parkinson's disease	0.000106	0.00108	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—GSTP1—Parkinson's disease	0.000105	0.00107	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—MAOA—Parkinson's disease	0.000105	0.00107	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.000105	0.00107	CbGpPWpGaD
Betaxolol—CYP1A2—Metapathway biotransformation—COMT—Parkinson's disease	0.000104	0.00106	CbGpPWpGaD
Betaxolol—CYP1A2—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000104	0.00106	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—RIT2—Parkinson's disease	9.86e-05	0.001	CbGpPWpGaD
Betaxolol—ADRB1—GPCR ligand binding—HTR2A—Parkinson's disease	9.74e-05	0.000993	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—ADORA2A—Parkinson's disease	9.72e-05	0.000991	CbGpPWpGaD
Betaxolol—CYP1A2—Biological oxidations—GSTM1—Parkinson's disease	9.68e-05	0.000987	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—RIT2—Parkinson's disease	9.64e-05	0.000983	CbGpPWpGaD
Betaxolol—CYP1A2—Metapathway biotransformation—GSTM1—Parkinson's disease	9.55e-05	0.000974	CbGpPWpGaD
Betaxolol—ADRB2—GPCR ligand binding—HTR2A—Parkinson's disease	9.53e-05	0.000971	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—ADORA2A—Parkinson's disease	9.51e-05	0.00097	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GRK5—Parkinson's disease	9.34e-05	0.000953	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—HTR1A—Parkinson's disease	9.29e-05	0.000947	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—TAC1—Parkinson's disease	9.15e-05	0.000933	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GRK5—Parkinson's disease	9.14e-05	0.000932	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—HTR1A—Parkinson's disease	9.09e-05	0.000927	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—DRD1—Parkinson's disease	8.97e-05	0.000915	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—TAC1—Parkinson's disease	8.95e-05	0.000912	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—DRD1—Parkinson's disease	8.78e-05	0.000895	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—DRD3—Parkinson's disease	8.69e-05	0.000886	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—DRD3—Parkinson's disease	8.5e-05	0.000867	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HTR1A—Parkinson's disease	8.44e-05	0.00086	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GRM4—Parkinson's disease	8.38e-05	0.000854	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—TAC1—Parkinson's disease	8.31e-05	0.000847	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HTR1A—Parkinson's disease	8.25e-05	0.000841	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GRM4—Parkinson's disease	8.2e-05	0.000836	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—DRD1—Parkinson's disease	8.15e-05	0.000831	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—TAC1—Parkinson's disease	8.13e-05	0.000829	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—ADRBK1—Parkinson's disease	8.11e-05	0.000827	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ND3—Parkinson's disease	8.1e-05	0.000826	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MCCC1—Parkinson's disease	8.1e-05	0.000826	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—DRD1—Parkinson's disease	7.97e-05	0.000813	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PENK—Parkinson's disease	7.94e-05	0.00081	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAG—Parkinson's disease	7.94e-05	0.00081	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—ADRBK1—Parkinson's disease	7.94e-05	0.000809	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—DRD3—Parkinson's disease	7.89e-05	0.000805	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—DRD2—Parkinson's disease	7.86e-05	0.000801	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—HTR7—Parkinson's disease	7.86e-05	0.000801	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PENK—Parkinson's disease	7.77e-05	0.000792	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAG—Parkinson's disease	7.77e-05	0.000792	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—DRD3—Parkinson's disease	7.72e-05	0.000787	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—DRD2—Parkinson's disease	7.69e-05	0.000784	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—HTR7—Parkinson's disease	7.69e-05	0.000784	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—OMD—Parkinson's disease	7.62e-05	0.000777	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—TALDO1—Parkinson's disease	7.62e-05	0.000777	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—ADRBK1—Parkinson's disease	7.37e-05	0.000751	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	7.29e-05	0.000743	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—PDYN—Parkinson's disease	7.27e-05	0.000741	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	7.22e-05	0.000736	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—ADRBK1—Parkinson's disease	7.21e-05	0.000735	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HTR7—Parkinson's disease	7.14e-05	0.000728	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—DRD2—Parkinson's disease	7.14e-05	0.000728	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—PDYN—Parkinson's disease	7.11e-05	0.000725	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—DRD2—Parkinson's disease	6.98e-05	0.000712	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HTR7—Parkinson's disease	6.98e-05	0.000712	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GCH1—Parkinson's disease	6.89e-05	0.000703	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MCCC1—Parkinson's disease	6.86e-05	0.0007	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ND3—Parkinson's disease	6.86e-05	0.0007	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GFAP—Parkinson's disease	6.83e-05	0.000697	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—GRM5—Parkinson's disease	6.75e-05	0.000689	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GFAP—Parkinson's disease	6.68e-05	0.000681	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—GRM5—Parkinson's disease	6.61e-05	0.000674	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—TALDO1—Parkinson's disease	6.45e-05	0.000658	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—OMD—Parkinson's disease	6.45e-05	0.000658	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—EDN1—Parkinson's disease	6.29e-05	0.000641	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—EDN1—Parkinson's disease	6.15e-05	0.000627	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—DBH—Parkinson's disease	6.14e-05	0.000626	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GBA—Parkinson's disease	6.14e-05	0.000626	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—FBP1—Parkinson's disease	6.14e-05	0.000626	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NDUFB11—Parkinson's disease	6.12e-05	0.000624	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FGF20—Parkinson's disease	5.92e-05	0.000604	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GCH1—Parkinson's disease	5.84e-05	0.000595	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FGF20—Parkinson's disease	5.79e-05	0.000591	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADORA2A—Parkinson's disease	5.74e-05	0.000586	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—EDN1—Parkinson's disease	5.71e-05	0.000583	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADORA2A—Parkinson's disease	5.62e-05	0.000573	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—EDN1—Parkinson's disease	5.59e-05	0.00057	CbGpPWpGaD
Betaxolol—ADRB1—GPCR downstream signaling—HTR2A—Parkinson's disease	5.5e-05	0.000561	CbGpPWpGaD
Betaxolol—ADRB2—GPCR downstream signaling—HTR2A—Parkinson's disease	5.38e-05	0.000549	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—INSR—Parkinson's disease	5.3e-05	0.00054	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	5.26e-05	0.000537	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GBA—Parkinson's disease	5.2e-05	0.00053	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—FBP1—Parkinson's disease	5.2e-05	0.00053	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—DBH—Parkinson's disease	5.2e-05	0.00053	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—INSR—Parkinson's disease	5.18e-05	0.000529	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—FGB—Parkinson's disease	5.01e-05	0.000511	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—HTR2A—Parkinson's disease	5e-05	0.00051	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR1A—Parkinson's disease	4.98e-05	0.000508	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—TAC1—Parkinson's disease	4.91e-05	0.0005	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—FGB—Parkinson's disease	4.9e-05	0.0005	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—HTR2A—Parkinson's disease	4.89e-05	0.000498	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR1A—Parkinson's disease	4.87e-05	0.000497	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—DRD1—Parkinson's disease	4.81e-05	0.000491	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—TAC1—Parkinson's disease	4.8e-05	0.000489	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—DRD1—Parkinson's disease	4.71e-05	0.00048	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—DRD3—Parkinson's disease	4.66e-05	0.000475	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—DRD3—Parkinson's disease	4.56e-05	0.000465	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—DDC—Parkinson's disease	4.51e-05	0.00046	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—ADRBK1—Parkinson's disease	4.35e-05	0.000444	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—ADRBK1—Parkinson's disease	4.26e-05	0.000434	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTA4—Parkinson's disease	4.26e-05	0.000434	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—DRD2—Parkinson's disease	4.22e-05	0.00043	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR7—Parkinson's disease	4.22e-05	0.00043	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR7—Parkinson's disease	4.12e-05	0.00042	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—DRD2—Parkinson's disease	4.12e-05	0.00042	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	3.83e-05	0.000391	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—DDC—Parkinson's disease	3.82e-05	0.000389	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MAOB—Parkinson's disease	3.79e-05	0.000387	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTA4—Parkinson's disease	3.61e-05	0.000368	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.56e-05	0.000363	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF2—Parkinson's disease	3.53e-05	0.00036	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF2—Parkinson's disease	3.46e-05	0.000352	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IGF1R—Parkinson's disease	3.42e-05	0.000348	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—EDN1—Parkinson's disease	3.37e-05	0.000344	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IGF1R—Parkinson's disease	3.34e-05	0.000341	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—EDN1—Parkinson's disease	3.3e-05	0.000337	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—PLA2G6—Parkinson's disease	3.25e-05	0.000331	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MAOB—Parkinson's disease	3.21e-05	0.000328	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—NGF—Parkinson's disease	3.1e-05	0.000316	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.06e-05	0.000312	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—NGF—Parkinson's disease	3.03e-05	0.000309	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—HTR2A—Parkinson's disease	2.95e-05	0.000301	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—HTR2A—Parkinson's disease	2.89e-05	0.000294	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.77e-05	0.000282	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—APOE—Parkinson's disease	2.74e-05	0.00028	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—APOE—Parkinson's disease	2.69e-05	0.000274	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	2.58e-05	0.000263	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—NQO1—Parkinson's disease	2.55e-05	0.00026	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—TH—Parkinson's disease	2.51e-05	0.000256	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—CYCS—Parkinson's disease	2.41e-05	0.000246	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP2D6—Parkinson's disease	2.39e-05	0.000244	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—INS—Parkinson's disease	2.34e-05	0.000239	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CTGF—Parkinson's disease	2.34e-05	0.000239	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—INS—Parkinson's disease	2.29e-05	0.000234	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYP2E1—Parkinson's disease	2.18e-05	0.000223	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—NQO1—Parkinson's disease	2.16e-05	0.00022	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—COMT—Parkinson's disease	2.14e-05	0.000218	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—TH—Parkinson's disease	2.13e-05	0.000217	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTP1—Parkinson's disease	2.13e-05	0.000217	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MAOA—Parkinson's disease	2.12e-05	0.000216	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—HMOX1—Parkinson's disease	2.1e-05	0.000214	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—CYCS—Parkinson's disease	2.04e-05	0.000208	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—ABCB1—Parkinson's disease	2.01e-05	0.000205	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.95e-05	0.000199	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.87e-05	0.000191	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—COMT—Parkinson's disease	1.81e-05	0.000185	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTP1—Parkinson's disease	1.8e-05	0.000184	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MAOA—Parkinson's disease	1.8e-05	0.000183	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—HMOX1—Parkinson's disease	1.78e-05	0.000181	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—CASP3—Parkinson's disease	1.75e-05	0.000178	CbGpPWpGaD
Betaxolol—ADRB1—Signaling by GPCR—IL6—Parkinson's disease	1.73e-05	0.000177	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.73e-05	0.000176	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—CASP3—Parkinson's disease	1.71e-05	0.000174	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—ABCB1—Parkinson's disease	1.71e-05	0.000174	CbGpPWpGaD
Betaxolol—ADRB2—Signaling by GPCR—IL6—Parkinson's disease	1.7e-05	0.000173	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GSTM1—Parkinson's disease	1.66e-05	0.000169	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—APOE—Parkinson's disease	1.61e-05	0.000164	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—MAPK8—Parkinson's disease	1.6e-05	0.000164	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—GPX1—Parkinson's disease	1.59e-05	0.000162	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—MAPK8—Parkinson's disease	1.57e-05	0.00016	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—MTHFR—Parkinson's disease	1.46e-05	0.000149	CbGpPWpGaD
Betaxolol—CYP2D6—Metabolism—INS—Parkinson's disease	1.37e-05	0.00014	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—APOE—Parkinson's disease	1.36e-05	0.000139	CbGpPWpGaD
Betaxolol—CYP1A2—Metabolism—INS—Parkinson's disease	1.16e-05	0.000119	CbGpPWpGaD
Betaxolol—ADRB1—Signaling Pathways—IL6—Parkinson's disease	1.02e-05	0.000104	CbGpPWpGaD
Betaxolol—ADRB2—Signaling Pathways—IL6—Parkinson's disease	1e-05	0.000102	CbGpPWpGaD
